Entrepreneurial pathways to impact: spinning-out your research
Hosted by Cambridge Innovation Capital in partnership with Cambridge Enterprise
Supported by Babraham Institute, Wellcome Sanger Institute, Start Codon and Deeptech Labs
In person event at the Clayton Hotel, Cambridge, on 29 September from 14.00-17.30 plus networking
The event will feature case studies, building around a ‘tasting menu’ of ideas and expertise, including sessions on Does good technology always look good, Who should you entrust managing your spin out to and Options for fundraising, culminating with an opportunity to meet the experts in person for conversation and networking.
- Introduction by Professor Andy Neely, Pro-Vice-Chancellor for Business and Enterprise Relations at the University of Cambridge
- Keynote - fireside chat with Professor Allan Bradley is a world-renowned researcher and serial academic entrepreneur. He is Emeritus Director of the Wellcome Trust Sanger Institute, and has established several biotechnology companies including Lexicon Pharmaceuticals Inc., which is publicly traded, Spectral Genomics Inc., which was acquired, Kymab Ltd and PetMedix.
- Case studies from Riverlane, Inivata, Secondmind and Porotech - on developing your idea, raising funds and creating a spin-out company
- An intensive afternoon, building around a ‘tasting menu’ of ideas and expertise, culminating with an opportunity to meet the experts in person for conversation and networking over refreshments
We are pleased to host this event in person at the Clayton Hotel, Station Road, Cambridge.
View the agenda